Home  »  Industry   »  Clovis Oncology Inc. (CLVS): Investors are paying ...

Clovis Oncology Inc. (CLVS): Investors are paying attention to this stock

Let’s start up with the current stock price of Clovis Oncology Inc. (CLVS), which is $1.12 to be very precise. The Stock rose vividly during the last session to $1.21 after opening rate of $1.21 while the lowest price it went was recorded $1.10 before closing at $1.23.Recently in News on September 13, 2022, Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer. Submissions based on data from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented at ASCO 2022. You can read further details here

Clovis Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.2500 on 07/08/22, with the lowest value was $0.5810 for the same time period, recorded on 06/13/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Clovis Oncology Inc. (CLVS) full year performance was -75.49%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Clovis Oncology Inc. shares are logging -77.19% during the 52-week period from high price, and 92.77% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.58 and $4.91.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2319701 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Clovis Oncology Inc. (CLVS) recorded performance in the market was -58.67%, having the revenues showcasing -31.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 175.91M, as it employees total of 413 workers.

Analysts verdict on Clovis Oncology Inc. (CLVS)

During the last month, 1 analysts gave the Clovis Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3861, with a change in the price was noted -1.13. In a similar fashion, Clovis Oncology Inc. posted a movement of -50.22% for the period of last 100 days, recording 10,178,868 in trading volumes.

Clovis Oncology Inc. (CLVS): Technical Analysis

Raw Stochastic average of Clovis Oncology Inc. in the period of last 50 days is set at 2.23%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.92%. In the last 20 days, the company’s Stochastic %K was 24.42% and its Stochastic %D was recorded 38.94%.

Let’s take a glance in the erstwhile performances of Clovis Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -58.67%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -28.21%, alongside a downfall of -75.49% for the period of the last 12 months. The shares increased approximately by -24.83% in the 7-day charts and went down by -17.65% in the period of the last 30 days. Common stock shares were lifted by -31.71% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts